Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-08-12 13:50Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 40.93 yuan, reflecting a 1.06% increase on August 12, 2025, amidst varying capital flows from different investor groups [1][2]. Financial Performance - For Q1 2025, Steady Medical reported a main revenue of 2.605 billion yuan, representing a year-on-year increase of 36.47% - The net profit attributable to shareholders was 249 million yuan, also up by 36.26% year-on-year - The net profit excluding non-recurring items reached 234 million yuan, marking a significant increase of 62.46% year-on-year - The company's debt ratio stands at 31.72%, with investment income of 459,100 yuan and financial expenses of 161,400 yuan - The gross margin is reported at 48.46% [3]. Market Position - Steady Medical's total market capitalization is 23.835 billion yuan, significantly higher than the industry average of 11.111 billion yuan, ranking 4th out of 28 in the beauty and personal care sector - The company's net assets amount to 12.146 billion yuan, leading the industry average of 3.38 billion yuan, ranking 1st out of 28 - The net profit of 249 million yuan places the company 3rd in the industry, while its price-to-earnings ratio (23.97) is lower than the industry average (41.39), ranking 6th out of 28 - The price-to-book ratio is 2.12, better than the industry average of 2.94, ranking 5th out of 28 - The company's net profit margin is 10.05%, above the industry average of 8.7%, ranking 11th out of 28 - Return on equity (ROE) is reported at 2.13%, slightly above the industry average of 1.91%, ranking 10th out of 28 [3]. Investor Sentiment - In the last 90 days, 16 institutions have rated the stock, with 13 buy ratings and 3 hold ratings - The average target price set by institutions over the past 90 days is 57.38 yuan [4].